Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Biological Therapy in Treating Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
- Status
- TERMINATED
- Phase
- NA
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
- Status
- UNKNOWN
- Phase
- PHASE2
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2